Merge Healthcare

TriMed Staff | | Health Imaging | Diagnostic Imaging
 
Functional Diffusion Mapping (fDM) from Merge Healthcare 
Merge Healthcare (Booth 4058) is displaying the capabilities of the firm’s Cedara I-Response, an application designed to support clinical trials workflows and oncology viewing.

Cedara I-Response supports key concepts of double-blind reading, registration, advanced segmentation, comparison of multiple time points and support for clinical trial rules and has three distinct analysis techniques.  

The base Lesion Analysis package streamlines the clinical trials workflow of creating/exporting the RECIST, WHO and Volume measurements.  The PET/CT Analysis package enables users to compare SUV values over multiple time points.  The Functional Diffusion Mapping (fDM) Analysis package can track changes in tumors at the metabolic or cellular level over multiple time points.  fDM is a patented MR tumor analysis technique. 

TriMed Staff

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.